Related Experiment Video
Updated: Sep 9, 2025

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
Drug Overdose Deaths Involving Stimulants - United States, January 2018-June 2024
Lauren J Tanz1, Kimberly D Miller1, Amanda T Dinwiddie1
1Division of Overdose Prevention, National Center for Injury Prevention and Control, CDC.
Stimulant overdose deaths are rising, particularly among older adults and specific racial/ethnic groups. This highlights an urgent need for expanded stimulant use disorder treatments and tailored prevention efforts.
Area of Science:
- Public Health
- Epidemiology
- Substance Use Disorders
Background:
- Drug overdose deaths involving stimulants have significantly increased in the United States since 2011.
- Stimulant involvement is a growing concern in the ongoing overdose crisis.
Purpose of the Study:
- To describe the characteristics of stimulant-involved overdose deaths.
- To analyze trends in stimulant-involved overdose deaths by drug type and race/ethnicity.
Main Methods:
- Utilized data from the CDC's State Unintentional Drug Overdose Reporting System (SUDORS) for January 2021-June 2024.
- Analyzed data from the CDC's National Vital Statistics System (NVSS) for 2018-2023 to examine trends.
Main Results:
- From January 2021 to June 2024, 59.0% of overdose deaths involved stimulants.
- Deaths involving stimulants without opioids were more common in older adults (≥45 years) with cardiovascular disease history.
- Stimulant overdose death rates increased significantly from 2018 to 2023, with notable rises in cocaine and psychostimulant deaths, especially among specific racial and ethnic minority groups.
Conclusions:
- The rise in stimulant-involved overdose deaths necessitates expanded access to evidence-based treatments for stimulant use disorder.
- There is a need to evaluate medication-based treatments and interventions for co-occurring substance use disorders.
- Prevention efforts must engage individuals who use stimulants and may be overlooked by opioid-focused initiatives.
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Abuse and Addiction: Pharmacological Phenomena
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

